We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$259B
AUM Growth
+$31.2B
Cap. Flow
+$19.7B
Cap. Flow %
7.63%
Top 10 Hldgs %
24.01%
Holding
10,422
New
1,312
Increased
3,605
Reduced
3,645
Closed
1,693

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.42%
3 Communication Services 1.04%
4 Healthcare 0.74%
5 Financials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDR
8626
DELISTED
Blonder Tongue Laboratories Inc
BDR
$17K ﹤0.01%
+36,309
New +$18.9K
PSV
8627
PUT
DELISTED
Hermitage Offshore Services Ltd.
PSV
$17K ﹤0.01%
1,180
-270
-19% -$3.46K
QTRH
8628
DELISTED
Quarterhill Inc. Common Shares
QTRH
$17K ﹤0.01%
+12,618
New +$17.4K
CXRX
8629
DELISTED
Concordia International Corp. Common Stock
CXRX
$17K ﹤0.01%
14,744
-103
-0.7% -$141
CYTR
8630
DELISTED
CytRx Corp
CYTR
$17K ﹤0.01%
6,782
-19,202
-74% -$64.9K
GPUS
8631
Hyperscale Data Inc
GPUS
$34.2M
0
BIOC
8632
CALL
DELISTED
Biocept, Inc.
BIOC
$16K ﹤0.01%
1
-3
-75% -$35.5K
CETXW
8633
DELISTED
Cemtrex Inc. Series 1 Warrant
CETXW
$16K ﹤0.01%
30,000
DNR
8634
CALL
DELISTED
Denbury Resources, Inc.
DNR
$16K ﹤0.01%
12,100
-46,400
-79% -$60.5K
AIM
8635
AIM ImmunoTech
AIM
$7.61M
$16K ﹤0.01%
+11
New +$19.3K
BNTCW
8636
DELISTED
Benitec Biopharma Limited
BNTCW
$15K ﹤0.01%
50,000
GNCA
8637
PUT
DELISTED
Genocea Biosciences, Inc.
GNCA
$15K ﹤0.01%
+1,275
New +$48.4K
ALIM
8638
CALL
DELISTED
Alimera Sciences
ALIM
$14K ﹤0.01%
+707
New +$15.1K
ALIM
8639
PUT
DELISTED
Alimera Sciences
ALIM
$14K ﹤0.01%
+667
New +$14.3K
EVFM
8640
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$14K ﹤0.01%
+331
New +$12.8K
KTOVW
8641
DELISTED
Kitov Pharma Ltd. Warrants
KTOVW
$14K ﹤0.01%
20,027
-7,864
-28% -$4.37K
NAVB
8642
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$14K ﹤0.01%
1,685
-870
-34% -$7.37K
GST
8643
PUT
DELISTED
Gastar Exploration Inc.
GST
$14K ﹤0.01%
15,600
+200
+1% +$149
THM
8644
International Tower Hill Mines
THM
$699M
$13K ﹤0.01%
24,443
-16,565
-40% -$8.97K
TULP
8645
Bloomia Holdings
TULP
$16.2M
$12K ﹤0.01%
+1,617
New +$11.8K
LODE icon
8646
Comstock
LODE
$266M
$12K ﹤0.01%
+306
New +$13.8K
PLX icon
8647
Protalix BioTherapeutics
PLX
$200M
$12K ﹤0.01%
2,079
-5,692
-73% -$36.5K
ARCT icon
8648
PUT
Arcturus Therapeutics
ARCT
$450M
$11K ﹤0.01%
+1,500
New +$11.3K
MYNDW
8649
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$11K ﹤0.01%
+14,100
New +$9.77K
GAU
8650
PUT
Galiano Gold
GAU
$620M
$10K ﹤0.01%
10,700
-35,800
-77% -$42K

Similar funds

Jeff Yass's Q3 2017 Portfolio in Review

As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $19.7B of net new capital in Q3 2017, opening 1,312 new positions and adding to 3,605 existing holdings. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $474M trimmed.

  • Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
  • Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
  • Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
  • Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
  • Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
  • Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
  • Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.

Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.